136 related articles for article (PubMed ID: 24607843)
1. Survival in patients with high-risk prostate cancer is predicted by miR-221, which regulates proliferation, apoptosis, and invasion of prostate cancer cells by inhibiting IRF2 and SOCS3.
Kneitz B; Krebs M; Kalogirou C; Schubert M; Joniau S; van Poppel H; Lerut E; Kneitz S; Scholz CJ; Ströbel P; Gessler M; Riedmiller H; Spahn M
Cancer Res; 2014 May; 74(9):2591-603. PubMed ID: 24607843
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-18a modulates P53 expression by targeting IRF2 in gastric cancer patients.
Chen YJ; Wu H; Zhu JM; Li XD; Luo SW; Dong L; Liu TT; Shen XZ
J Gastroenterol Hepatol; 2016 Jan; 31(1):155-63. PubMed ID: 26173586
[TBL] [Abstract][Full Text] [Related]
3. miR-2909 regulates ISGylation system via STAT1 signalling through negative regulation of SOCS3 in prostate cancer.
Ayub SG; Kaul D
Andrology; 2017 Jul; 5(4):790-797. PubMed ID: 28622443
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer.
Hulf T; Sibbritt T; Wiklund ED; Patterson K; Song JZ; Stirzaker C; Qu W; Nair S; Horvath LG; Armstrong NJ; Kench JG; Sutherland RL; Clark SJ
Oncogene; 2013 Jun; 32(23):2891-9. PubMed ID: 22869146
[TBL] [Abstract][Full Text] [Related]
5. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
Hagman Z; Larne O; Edsjö A; Bjartell A; Ehrnström RA; Ulmert D; Lilja H; Ceder Y
Int J Cancer; 2010 Dec; 127(12):2768-76. PubMed ID: 21351256
[TBL] [Abstract][Full Text] [Related]
6. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.
Oguro T; Ishibashi K; Sugino T; Hashimoto K; Tomita S; Takahashi N; Yanagida T; Haga N; Aikawa K; Suzutani T; Yamaguchi O; Kojima Y
Eur J Cancer; 2013 May; 49(7):1715-24. PubMed ID: 23274199
[TBL] [Abstract][Full Text] [Related]
7. Regulation of miR-155 affects pancreatic cancer cell invasiveness and migration by modulating the STAT3 signaling pathway through SOCS1.
Huang C; Li H; Wu W; Jiang T; Qiu Z
Oncol Rep; 2013 Sep; 30(3):1223-30. PubMed ID: 23817566
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-146b acts as a potential tumor suppressor in human prostate cancer.
Ding HY; Qian WQ; Xu J
J BUON; 2016; 21(2):434-43. PubMed ID: 27273955
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
Shen PF; Chen XQ; Liao YC; Chen N; Zhou Q; Wei Q; Li X; Wang J; Zeng H
Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy.
Kristensen H; Haldrup C; Strand S; Mundbjerg K; Mortensen MM; Thorsen K; Ostenfeld MS; Wild PJ; Arsov C; Goering W; Visakorpi T; Egevad L; Lindberg J; Grönberg H; Høyer S; Borre M; Ørntoft TF; Sørensen KD
Clin Cancer Res; 2014 Apr; 20(8):2169-81. PubMed ID: 24737792
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.
Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ
Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066
[TBL] [Abstract][Full Text] [Related]
12. miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.
Larne O; Hagman Z; Lilja H; Bjartell A; Edsjö A; Ceder Y
Carcinogenesis; 2015 Aug; 36(8):858-66. PubMed ID: 25969144
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-613 represses prostate cancer cell proliferation and invasion through targeting Frizzled7.
Ren W; Li C; Duan W; Du S; Yang F; Zhou J; Xing J
Biochem Biophys Res Commun; 2016 Jan; 469(3):633-8. PubMed ID: 26703210
[TBL] [Abstract][Full Text] [Related]
14. Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer.
Goto Y; Nishikawa R; Kojima S; Chiyomaru T; Enokida H; Inoguchi S; Kinoshita T; Fuse M; Sakamoto S; Nakagawa M; Naya Y; Ichikawa T; Seki N
FEBS Lett; 2014 May; 588(10):1973-82. PubMed ID: 24768995
[TBL] [Abstract][Full Text] [Related]
15. miR-221 Augments TRAIL-Mediated Apoptosis in Prostate Cancer Cells by Inducing Endogenous TRAIL Expression and Targeting the Functional Repressors SOCS3 and PIK3R1.
Krebs M; Behrmann C; Kalogirou C; Sokolakis I; Kneitz S; Kruithof-de Julio M; Zoni E; Rech A; Schilling B; Kübler H; Spahn M; Kneitz B
Biomed Res Int; 2019; 2019():6392748. PubMed ID: 31828111
[TBL] [Abstract][Full Text] [Related]
16. miR-129 predicts prognosis and inhibits cell growth in human prostate carcinoma.
Xu S; Yi XM; Zhang ZY; Ge JP; Zhou WQ
Mol Med Rep; 2016 Dec; 14(6):5025-5032. PubMed ID: 27779679
[TBL] [Abstract][Full Text] [Related]
17. STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells.
Cheng Y; Li Y; Nian Y; Liu D; Dai F; Zhang J
BMC Cancer; 2015 Apr; 15():306. PubMed ID: 25928665
[TBL] [Abstract][Full Text] [Related]
18. miR-302b inhibits cancer-related inflammation by targeting ERBB4, IRF2 and CXCR4 in esophageal cancer.
Zhang M; Zhang L; Cui M; Ye W; Zhang P; Zhou S; Wang J
Oncotarget; 2017 Jul; 8(30):49053-49063. PubMed ID: 28467773
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
20. microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells.
Mao Y; Chen H; Lin Y; Xu X; Hu Z; Zhu Y; Wu J; Xu X; Zheng X; Xie L
Oncol Rep; 2013 Jul; 30(1):327-33. PubMed ID: 23670210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
